FR:R2EH
State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR
€9.34
State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR (FR:R2EH) Price & Chart
FR:R2EH ETF Chart & Stats
€9.34
At close: 4:00 PM EST- Day’s Range
- EUR 9.40 - EUR 9.40
- 52-Week Range
- EUR 9.14 - EUR 10.33
- Previous Close
- EUR 9.51
- Volume
- 0
- Average Volume (3M)
- 8,452
- AUM
- 149.00M
- NAV
- 9.40
- Expense Ratio
- 0.46%
- Holdings Count
- 1,910
- Beta
- 0.26
- Inception Date
- Jun 15, 2026
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 15,590,633
- Standard Deviation
- N/A
ETF Overview
State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR
State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR (FR:R2EH) provides European investors with diversified, passive exposure to the performance of the U.S. small‑cap equity market by tracking the Russell 2000 Index. As a Size & Style – Small Cap, Broad‑based ETF, it captures around 2,000 smaller U.S. companies across sectors, offering broad, market‑cap‑weighted access to the domestic small‑capitalization segment that historically has delivered higher growth potential (and higher volatility) than large‑cap equities. The fund is a UCITS vehicle managed by State Street’s SPDR platform, uses an accumulating share class that reinvests dividends to enhance compounding, and employs a euro‑hedged share class to mitigate USD/EUR currency fluctuations for euro‑based investors. Designed as a core building block for a diversified equity allocation or as a targeted way to add small‑cap exposure, the ETF aims to replicate the Russell 2000’s return before fees and hedging costs, while retaining the liquidity and regulatory oversight associated with UCITS products. Investors should expect greater sensitivity to economic cycles and company‑specific risk compared with large‑cap funds, making it most suitable for those with a longer investment horizon and a tolerance for higher short‑term volatility.
- Asset Class
- Equity
- Region
- North America
- Issuer
- SPDR
- Index Tracked
- Russell 2000 Index - EUR - Benchmark TR Net Hedged
- Ticker Symbol
- FR:R2EH
FR:R2EH ETF News
Vaxcyte Study Update: VAX-31 Trial Completion Sets Up a Key Data Catalyst
Vaxcyte, Inc. ($PCVX) announced an update on their ongoing clinical study. Study Overview: The official title is A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability,
1d agoPCVX
Vaxcyte’s VAX-31 Study Reaches Completion, but Investors Await Results
Vaxcyte, Inc. ($PCVX) announced an update on their ongoing clinical study. Study Overview: Vaxcyte’s Phase 3 study, officially titled “A Phase 3, Randomized, Double-Blind, Active-Controlled Clinical Study to Evaluate the
1d agoPCVX
FR:R2EH ETF FAQ
What was FR:R2EH’s price range in the past 12 months?
FR:R2EH’s lowest price in the past 12 months was EUR 9.14 and its highest was EUR 10.33.
What is the AUM of FR:R2EH?
As of Nov 13, 2026, the AUM of FR:R2EH is €149.00M.
Is FR:R2EH overvalued?
Based on Wall Street analyst price targets for FR:R2EH’s holdings, FR:R2EH’s price is currently undervalued.
How many shares outstanding does FR:R2EH have?
FR:R2EH has 15,590,633 shares outstanding.
FR:R2EH ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| GKOSGlaukos Corp. | 0.47% |
| BTSGBrightSpring Health Services, Inc. | 0.40% |
| FROGJfrog Ltd. | 0.40% |
| UMBFUmb Financial Corp. | 0.34% |
| VSATViaSat Inc | 0.33% |
| MOG.AMoog Inc. | 0.33% |
| TGTXTG Therapeutics | 0.31% |
| PCVXVaxcyte, Inc. | 0.31% |
| RHPRyman Hospitality Properties | 0.31% |
| CTRECareTrust REIT | 0.30% |
| Total | 3.52% |
